Table 2.
Tissue | Species | Response | Intervention | Outcome | Reference |
---|---|---|---|---|---|
In vivo treatments | |||||
White adipocytes | Hamster | Lipolysis | Noradrenaline 5 μg·min−1·kg−1 infusion, 6 days | No change | Carpene et al., 1993 |
White adipocytes | Rat | Oxygen consumption | FR 149,175, 0.1–3.2 mg·kg−1 twice daily orally, 2 weeks | No change | Hatakeyama, Sakata, Takakura, Manda, & Mutoh, 2004 |
Ileum | Mouse | Relaxation | CL 316,243, 1 mg·kg−1 injection, 1 hr | No change | Hutchinson, Evans, & Summers, 2000 |
CL 316,243, 1 mg·kg−1 injection, 4 or 24 hr | Reduced | ||||
Pulmonary artery | Rat | Relaxation | Isoprenaline 0.3 mg·kg−1·day−1 injection, 7 days | No change | Davel, Victorio, Delbin, Fukuda, & Rossoni, 2015 |
In vitro treatments | |||||
Myometrium | Human | Relaxation | SR 59,119, 10 μM, 5 or 15 hr | No change | Rouget et al., 2004 |
Urinary bladder | Rat | Relaxation | Isoprenaline, CL 316,243, mirabegron 10 μM each, 6 hr | No change | Michel, 2014 |
Note: For details, see Section 2.